Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
60.0%
% of BBH's 27 holdings also in HELX
26.8%
% of HELX's 62 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus HELX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 10.8% | 5.6% | 5.6% |
|
REGENERON PHARMACEUTICALS | 6.5% | 5.3% | 5.3% |
|
NATERA INC | 4.0% | 3.1% | 3.1% |
|
MODERNA, INC. | 2.6% | 2.5% | 2.5% |
|
INSMED INC | 2.2% | 2.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to HELX
|
AMGEN INC | 15.3% |
|
GILEAD SCIENCES INC | 10.9% |
 |
ARGENX SE ADR | 5.6% |
|
VERTEX PHARMACEUTICALS INC | 5.2% |
|
ILLUMINA INC | 4.4% |
|
BIOGEN IDEC INC | 3.6% |
|
IQVIA HOLDINGS INC | 3.5% |
|
QIAGEN NV | 2.0% |
|
BIOMARIN PHARMACEUTICAL INC | 2.0% |
|
ALNYLAM PHARMACEUTICALS INC | 1.8% |
BBH Underweight Relative to HELX
|
MEDPACE HOLDINGS, INC. | -6.4% |
|
DANAHER CORP | -5.2% |
|
KRYSTAL BIOTECH, INC. | -5.0% |
|
THERMO FISHER SCIENTIFIC INC | -4.9% |
|
ELI LILLY & CO | -4.2% |
 |
SAMSUNG BIOLOGICS CO., LTD. | -3.3% |
|
IONIS PHARMACEUTICALS, INC. | -2.7% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.6% |
|
BRUKER CORP | -2.4% |
 |
SARTORIUS AG PREF | -2.1% |